pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 258 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings258
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07531394: Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Ischemic Stroke, Acute, Myocardial Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Medulloblastoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07461766: Food and Nutrition Education for Adolescent Soccer Players

Sponsor: Federal University of São Paulo. Phase: NA. Conditions: Nutritional Assessments, Adolescent Athletic Performance, Premenstrual Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT03524222: Home Hospital for Suddenly Ill Adults

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Infection, Heart Failure, COPD, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05656651: Acute Immunological Effects of Exercise in Cancer Patients

Sponsor: Universität Duisburg-Essen. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473531: Chatbot to Support Healthcare Professionals Experiencing Workplace Aggression

Sponsor: Distrito Sanitario Almeria. Phase: . Conditions: Workplace Violence, Health Professionals, Chatbot, Digital Health

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427472: "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Heterozygous Familial Hypercholesterolemia (HeFH)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07465939: Dento-skeletal Effects of Quadhelix Versus Mini-hyrax Expanders in Patients With Cleft Lip and Palate at the Mixed Dentition Stage: A Randomized Clinical Trial

Sponsor: Cairo University. Phase: NA. Conditions: Maxillary Expansion in Cleft Lip and Palate Patients, Dentoskeletal Effects After Expansion Using Two Different Expanders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569575: Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

Sponsor: HuaMg Perfection Med Tech (Suzhou) Co., Ltd.. Phase: NA. Conditions: Tibial Fracture, Femoral Fracture, Humeral Fracture

full page →ctgov ↗
›RECRUITINGphase readoutNCT07422675: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Sponsor: Serina Therapeutics. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07439575: Wound Closure Materials and Techniques in Hip and Knee Arthroplasty

Sponsor: Bahattin Kemah. Phase: NA. Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip

full page →ctgov ↗
›RECRUITINGphase readoutNCT06851975: Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

Sponsor: Centre Antoine Lacassagne. Phase: . Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06503575: Adolescent Idiopathic Scoliosis and Body Schema

Sponsor: Acibadem University. Phase: . Conditions: Adolescent Idiopathic Scoliosis, Body Schema

full page →ctgov ↗
›RECRUITINGphase readoutNCT06783595: Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone

Sponsor: Loma Linda University. Phase: . Conditions: Tooth Loss, Implant Site Reaction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07477067: Exercise and Protein Efficiency in T2D

Sponsor: University of Illinois at Urbana-Champaign. Phase: NA. Conditions: Type 2 Diabetes, Control Condition

full page →ctgov ↗
›RECRUITINGphase readoutNCT06805630: Urine Methylation Markers in UTUC

Sponsor: Duke University. Phase: NA. Conditions: Upper Tract Urothelial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05603000: Emotion Focused Family Therapy for Parents of Children With Mental Health Difficulties

Sponsor: University of Guelph. Phase: NA. Conditions: Anxiety, Depression, Behavior Problem

full page →ctgov ↗
›RECRUITINGphase readoutNCT06477900: Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH)

Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: NA. Conditions: PreDiabetes

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06445400: A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: HER2-positive Breast Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07359807: A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

Sponsor: Concept Medical Inc.. Phase: PHASE2. Conditions: Popliteal Artery Disease, Superficial Femoral Artery Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04928807: Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE3. Conditions: Rectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07582107: Anatomical Landmark Method for Paediatric Port Catheter Tip Positioning

Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Central Venous Catheterization, Vascular Access Devices, Pediatric Patients, Monitoring

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07552792: Impact of Hand Rub Placement on Patient Trust and Disease Stigma

Sponsor: Huashan Hospital. Phase: NA. Conditions: Noncommunicable Disease, Psoriasis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07379034: The Effect of ShotBlocker and Vibration on Pain During Vaccination

Sponsor: Ataturk University. Phase: NA. Conditions: Vaccination, Pain, Infant, Shotblocker, Vibration

full page →ctgov ↗
›COMPLETEDphase readoutNCT02432534: Atorvastatin in Active Vitiligo

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo

full page →ctgov ↗
›RECRUITINGphase readoutNCT06017934: Promoting Increased Physical Activity in Hospitalised Older Adults

Sponsor: University of Southampton. Phase: NA. Conditions: Hospital-associated Deconditioning

full page →ctgov ↗
›RECRUITINGphase readoutNCT06332209: Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Post-Traumatic Stress Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06632509: BD SiteRite(TM) 9 Ultrasound System - Clinical Study

Sponsor: Becton, Dickinson and Company. Phase: . Conditions: BD SiteRite 9 for VAD Insertion

full page →ctgov ↗
›COMPLETEDphase readoutNCT02007499: Pre-arrival Instructions Effect on Bystander Cardiopulmonary Resuscitation (CPR).

Sponsor: Medical College of Wisconsin. Phase: . Conditions: Heart Arrest, Cardiac Arrest, Cardiopulmonary Arrest, Out of Hospital Cardiac Arrest, Sudden Cardiac Death

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01545999: Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07105098: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

Sponsor: Neurocrine Biosciences. Phase: PHASE3. Conditions: Schizophrenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07513363: The Role of Urinary RhoA, NGF, and BDNF Levels in Overactive Bladder and Vitamin D Deficiency

Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Overactive Bladder, Vitamin D Deficiency

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05777993: A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

Sponsor: Agios Pharmaceuticals, Inc.. Phase: PHASE4. Conditions: Pyruvate Kinase Deficiency, Anemia, Hemolytic

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06832293: My MS and My Menstrual Cycle

Sponsor: University of Alberta. Phase: . Conditions: Multiple Sclerosis, Menstrual Cycle

full page →ctgov ↗
›COMPLETEDphase readoutNCT06783621: A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

Sponsor: AbbVie. Phase: PHASE4. Conditions: Facial Contouring

full page →ctgov ↗
›COMPLETEDphase readoutNCT06044714: Effects of Acupuncture on Perceived Stress and Health in Military Service Members

Sponsor: United States Naval Medical Center, San Diego. Phase: NA. Conditions: Perceived Stress

full page →ctgov ↗
›RECRUITINGphase readoutNCT07505004: Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

Sponsor: Praxis Precision Medicines. Phase: PHASE3. Conditions: Focal Epilepsy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT02636504: Evaluation of Three Pulp Vitality Tests

Sponsor: Columbia University. Phase: . Conditions: Dental Pulp Diseases, Dental Pulp Vitality Testing

full page →ctgov ↗
›RECRUITINGphase readoutNCT07459504: SMART Diets for MASLD

Sponsor: Michigan State University. Phase: PHASE2. Conditions: Metabolic-dysfunction Associated Steatotic Liver Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT01050504: Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Sponsor: University of Washington. Phase: . Conditions: Localized Renal Pelvis and Ureter Urothelial Carcinoma, Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Soft Tissues, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Recurrent Bladder Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Pelvis and Ureter Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v7, Stage IV Bladder Urothelial Carcinoma AJCC v7, Stage IV Prostate Cancer AJCC v7

full page →ctgov ↗
›COMPLETEDphase readoutNCT04577404: Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Sponsor: Tanabe Pharma America, Inc.. Phase: PHASE3. Conditions: Amyotrophic Lateral Sclerosis (ALS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07336147: Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Sponsor: Chang Gung Memorial Hospital. Phase: PHASE2. Conditions: Female

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07397247: Tonic Motor Activation (TOMAC) Therapy in Patients With Restless Legs Syndrome and Dopaminergic Augmentation

Sponsor: Noctrix Health, Inc.. Phase: NA. Conditions: Restless Legs Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05030038: Oral Aromatase Inhibitors Modify the Gut Microbiome

Sponsor: Wake Forest University Health Sciences. Phase: . Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07357558: A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia

Sponsor: University Hospital Southampton NHS Foundation Trust. Phase: . Conditions: Primary Ciliary Dyskinesia (PCD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05070858: A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis

Sponsor: Regeneron Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Myasthenia Gravis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07145658: Multivitamin for Health and Cognition

Sponsor: Dr Anthony Hobson. Phase: NA. Conditions: Healthy, Cognition, Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT06666348: Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK

Sponsor: St. Justine's Hospital. Phase: PHASE1. Conditions: Pediatric Low-grade Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06471426: The Effect of Osteopathic Treatment on Craniocervico-Mandibular Dysfunction

Sponsor: Edward Via Virginia College of Osteopathic Medicine. Phase: NA. Conditions: Headache, Neck Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT03328026: Combination Study of SV-BR-1-GM With Retifanlimab

Sponsor: BriaCell Therapeutics Corporation. Phase: PHASE1. Conditions: Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer, Breast Cancer Metastatic

full page →ctgov ↗
← prev
page 92 of 161
next →